Cargando…
Clinical Pharmacology‐Driven Translational Research to Optimize Bedside Therapeutics of Sotalol Therapy
Oral sotalol, used in adults for sinus rhythm control, is initiated at 80 mg b.i.d. and titrated to a maximum safe dose. The US Food and Drug Administration recommends monitoring the corrected QT interval (QT(c)) for at least 3 days, until steady‐state exposure of the drug is reached, before patient...
Autores principales: | Dahmane, Elyes, Tang, Kathy, Gobburu, Jogarao V.S., Mattingly, T. Joseph, Reed, Brent N., See, Vincent Y., Ayres, Joshuha, Ivaturi, Vijay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6853149/ https://www.ncbi.nlm.nih.gov/pubmed/31328888 http://dx.doi.org/10.1111/cts.12670 |
Ejemplares similares
-
Dosage Regimens for Meropenem in Children with Pseudomonas Infections Do Not Meet Serum Concentration Targets
por: Hassan, Hazem E., et al.
Publicado: (2019) -
Outpatient intravenous sotalol load to replace 3-day admission oral sotalol load
por: Von Bergen, Nicholas H., et al.
Publicado: (2019) -
Sorafenib Dose Recommendation in Acute Myeloid Leukemia Based on Exposure‐FLT3 Relationship
por: Liu, Tao, et al.
Publicado: (2018) -
Could Postnatal Age–Related Uridine Diphosphate Glucuronic Acid Be a Rate‐Limiting Factor in the Metabolism of Morphine During the First Week of Life?
por: Liu, Tao, et al.
Publicado: (2019) -
Clearance of Sotalol on continuous venovenous haemofiltration
por: Roberts, H, et al.
Publicado: (2005)